Fatemeh Behjati Ardakani

Fatemeh Behjati Ardakani

Auto-generated profile, based on publicly available information

Fatemeh Behjati Ardakani

Institute for Computational Genomic Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in GigaScience
Verified
Journal Article
Open access
FAFatemeh Behjati Ardakani
Fatemeh Behjati Ardakani
Kathrin KattlerKathrin Kattler
Kathrin Kattler
THTobias Heinen
Tobias Heinen
FSFlorian Schmidt
Florian Schmidt
DFDavid Feuerborn
David Feuerborn
MSMarcel Schulz
Marcel Schulz
Background: Single-cell RNA sequencing is a powerful technology to discover new cell types and study biological processes in complex biological samples. A current challenge is to predict transcription factor (TF) regulation from single-cell RNA data. Results: Here, we propose a novel approach for predicting gene expression at the single-cell level using cis-regulatory motifs, as well as epigenetic features. We designed a tree-guided multi-task learning framework that considers each cell as a task. Through this framework we were able to explain the single-cell gene expression values using either TF binding affinities or TF ChIP-seq data measured at specific genomic regions. TFs identified using these models could be validated by the literature. Conclusion: Our proposed method allows us to identify distinct TFs that show cell type–specific regulation. This approach is not limited to TFs but can use any type of data that can potentially be used in explaining gene expression at the single-cell level to study factors that drive differentiation or show abnormal regulation in disease. The implementation of our workflow can be accessed under an MIT license via https://github.com/SchulzLab/Triangulate.

2 September 2019 in F1000Research
Verified
Journal Article
Open access
FAFatemeh Behjati Ardakani
Fatemeh Behjati Ardakani
FSFlorian Schmidt
Florian Schmidt
MSMarcel Schulz
Marcel Schulz
Background: Understanding the location and cell-type specific binding of Transcription Factors (TFs) is important in the study of gene regulation. Computational prediction of TF binding sites is challenging, because TFs often bind only to short DNA motifs and cell-type specific co-factors may work together with the same TF to determine binding. Here, we consider the problem of learning a general model for the prediction of TF binding using DNase1-seq data and TF motif description in form of position specific energy matrices (PSEMs). Methods: We use TF ChIP-seq data as a gold-standard for model training and evaluation. Our contribution is a novel ensemble learning approach using random forest classifiers. In the context of the ENCODE-DREAM in vivo TF binding site prediction challenge we consider different learning setups. Results: Our results indicate that the ensemble learning approach is able to better generalize across tissues and cell-types compared to individual tissue-specific classifiers or a classifier built based upon data aggregated across tissues. Furthermore, we show that incorporating DNase1-seq peaks is essential to reduce the false positive rate of TF binding predictions compared to considering the raw DNase1 signal. Conclusions: Analysis of important features reveals that the models preferentially select motifs of other TFs that are close interaction partners in existing protein protein-interaction networks. Code generated in the scope of this project is available on GitHub: https://github.com/SchulzLab/TFAnalysis (DOI: 10.5281/zenodo.1409697).

26 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
QMQuirin Manz
Quirin Manz
MBMisha Bilenky
Misha Bilenky
DHDennis Hecker
Dennis Hecker
NANihit Aggarwal
Nihit Aggarwal
JGJuliana Estefania Arcila Galvis
Juliana Estefania Arcila Galvis
MHMartin Hirst
Martin Hirst
The sequence of the human genome provides a foundation for understanding cellular processes in health and disease. The organisation of this primary genetic information into cell-specific structure and function is critical to understanding the cell type-specific interpretation and execution of the genome. Epigenetic processes are essential for packaging and higher-level functional organisation of the genome, and changes therein are increasingly recognised as contributors to human disease. Building on primary data generated by multinational consortia, the International Human Epigenome Consortium (IHEC) has uniformly processed a collection of more than 2000 comprehensive human reference epigenomes, collectively referred to as EpiATLAS. This effort involved the development of standardised molecular and bioinformatics protocols, metadata models, and analytical tools to manage, integrate, display, and share vast amounts of epigenomic data. This includes the creation of a publicly available Epigenome Reference Registry, which provides a system for accessing protected human subject datasets and facilitates open searching of de-identified samples and experimental data. The integrated EpiATLAS ecosystem and its comprehensive human reference epigenome maps provide an unprecedented resource for the biosciences, expanding the annotated epigenomic landscape while uncovering previously unappreciated relationships among regulatory layers and revealing how epigenetic inputs underpin fundamental cellular functions and disease associations.

28 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DHDennis Hecker
Dennis Hecker
FAFatemeh Behjati Ardakani
Fatemeh Behjati Ardakani
AKAlexander Karollus
Alexander Karollus
JGJulien Gagneur
Julien Gagneur
MSMarcel Schulz
Marcel Schulz
Identifying regulatory regions in the genome is of great interest for understanding the epigenomic landscape in cells. One fundamental challenge in this context is to find the target genes whose expression is affected by the regulatory regions. A recent successful method is the Activity-By-Contact (ABC) model (Fulco et al., 2019) which scores enhancer-gene interactions based on enhancer activity and the contact frequency of an enhancer to its target gene. However, it describes regulatory interactions entirely from a gene’s perspective, and does not account for all the candidate target genes of an enhancer. In addition, the ABC-model requires two types of assays to measure enhancer activity, which limits the applicability. Moreover, there is no implementation available that could allow for an integration with transcription factor (TF) binding information nor an efficient analysis of single-cell data. We demonstrate that the ABC-score can yield a higher accuracy by adapting the enhancer activity according to the number of contacts the enhancer has to its candidate target genes and also by considering all annotated transcription start sites of a gene. Further, we show that the model is comparably accurate with only one assay to measure enhancer activity. We combined our generalised ABC-model (gABC) with TF binding information and illustrate an analysis of a single-cell ATAC-seq data set of the human heart, where we were able to characterise cell type-specific regulatory interactions and predict gene expression based on transcription factor affinities. All executed processing steps are incorporated into our new computational pipeline STARE. The software is available at https://github.com/schulzlab/STARE .
1

1 November 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
MJMariano Ruz Jurado
Mariano Ruz Jurado
DMDavid Rodriguez Morales
David Rodriguez Morales
EGElijah Genetzakis
Elijah Genetzakis
FAFatemeh Behjati Ardakani
Fatemeh Behjati Ardakani
LZLukas Zanders
Lukas Zanders
DJDavid John
David John
Single-cell transcriptomics offers critical insights into the molecular mechanisms of heart failure (HF) with reduced or preserved ejection fraction. However, understanding these mechanisms is hindered by the growing complexity of single-cell data and the difficulty in unmasking meaningful differential gene signatures among HF types. Machine learning, particularly deep neural networks (NNs), address these challenges by learning transcriptional patterns, reconstructing expression profiles and effectively classifying cells but often lacks interpretability. Recent advances in explainable AI (XAI) offer tools to clarify model decisions. Yet pinpointing differentially regulated genes with these tools remains challenging. We introduce a novel method to identify differentially explained genes (DXGs) based on importance scores derived from custom-built NNs. We highlight the superiority of DXGs in identifying HF subtypes-specific pathways that provide new insights into different types of HF. Offering a robust foundation for future research and therapeutic exploration in expanding transcriptome atlases.

13 July 2026 in Genome Biology
Verified
Journal Article
Open access
PDF file
FAFatemeh Behjati Ardakani
Fatemeh Behjati Ardakani
SAShamim Ashrafiyan
Shamim Ashrafiyan
LRLaura Rumpf
Laura Rumpf
DHDennis Hecker
Dennis Hecker
MSMarcel Schulz
Marcel Schulz
Background: Understanding how epigenome variation contributes to gene expression in disease and development is a fundamental challenge. Regulatory regions show cell type-specific epigenome activity and differ in their location, size, and distance to their target genes, complicating discovery and analysis. Recent machine learning models have been proposed to address these problems by learning functions for the prediction of gene expression from epigenomic data. Results: Here, we use the large IHEC EpiATLAS dataset to benchmark state-of-the-art linear and nonlinear approaches. We optimize each approach for over 28,000 human genes, providing an inferred regulatory catalog of gene models. In-depth comparison reveals that gene characteristics and the epigenomic complexity of the locus influence the difficulty of predicting the epigenome-to-transcriptome association. The model performance is further evaluated using CRISPRi and eQTL validation data. Based on these models, we conduct histone-acetylation association studies in a systematic way to investigate how epigenetic variation impacts gene expression. The model-based analysis revealed genes and regulatory regions linked to B-cell leukemia in patient data with known disease-related functions. Conclusions: Our work provides a foundation for applications that link epigenome variation to gene expression in human cells, by benchmarking methods on a per-gene basis, illustrating their use in a disease context and making trained models available to the community.